(Q61917834)

English

Safety of Avonex Treatment in Multiple Sclerosis Patients With Neutralizing Antibodies to Interferon Beta Therapy

clinical trial

Statements

SAFE (English)
0 references
A Swedish Multi-Centre, Prospective, Open Label Study: Safety of Avonex Treatment in Multiple Sclerosis Patients Who Are NAB Positive on Previous s.c Interferon Beta Therapy (English)
0 references
0 references
0 references
0 references
0 references
May 2004
0 references
May 2006
0 references
3
0 references
18 year
0 references
55 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit